Gujarat Themis Biosyn Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

7.26

7.26

7.26

7.26

7.26

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

194.11

141.88

96.06

62.68

34.93

Loan funds

Secured loans

-

-

-

-

3.18

Unsecured loans

-

-

-

-

-

Total

201.38

149.15

103.32

69.95

45.38

Uses of funds

Fixed assets

Gross block

49.98

42.24

27.19

27.59

21.93

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

11.96

9.58

7.76

8.65

4.85

Net block

38.02

32.66

19.43

18.95

17.08

Capital work-in-progress

91.22

20.59

12.70

2.07

0.36

Investments

-

-

-

-

0.01

Net current assets

Current assets, loans & advances

91.87

113.07

90.37

67.25

46.63

Less : current liabilities & provisions

19.74

17.18

19.18

18.32

18.70

Total net current assets

72.14

95.89

71.19

48.93

27.94

Miscellaneous expenses not written

-

-

-

-

-

Total

201.38

149.15

103.32

69.95

45.38

Notes:

Book value of unquoted investments

-

-

-

-

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

10.60

21.14

6.64

4.89

3.91

Number of equity sharesoutstanding (Lacs)

726.44

145.29

145.29

145.29

145.29